News | April 15, 2007

Live Total Knee Replacement Surgery with CAS System Viewable Online Wednesday

April 16, 2007 - On Wednesday, April 18 at 4PM EDT, Web viewers will have a unique opportunity to witness a "live" total knee replacement surgical procedure that employs a state-of-the-art Computer-Assisted Surgery (CAS) system from ORTHOsoft Inc. ORTHOsoft is an international company that develops and markets software applications, instruments and computerized medical systems that improve the accuracy of knee, hip and spine procedures.

The "live" Web cast will originate from Tampa General Hospital (Tampa, Florida). Kenneth Gustke, M.D., founding member of the American Association of Hip and Knee Surgeons, will perform the total knee replacement surgery. The procedure will be narrated by Steven Lyons, M.D., surgeon at the Florida Orthopaedic Institute.

CAS, such as with ORTHOsoft Navitrack Navigation Systems, provides surgeons immediate instrument alignment and implant placement feedback. With CAS, hip, knee, and ankle replacement adjustments surgeons can have a perfect alignment rate up to 98 percent.

The prime benefit for patients when surgeons use CAS is shorter post- surgery recovery time.

To see the "live" procedure on the Internet visit and click on the Web cast link on the right side of the home page.

To see Web Cast you will need to have RealPlayer

For more information about ORTHOsoft's Navitrack Navigation System visit:

Related Content

ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Contrast Media | August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
Contrast Media from Bayer, trends in contrast media and developments in contrast media
Feature | Contrast Media | July 28, 2017 | By Dave Fornell
Here are several updates in medical imaging ...
Guerbet Announces Plans to Streamline Contrast Media Portfolio, gadolinium MRI contrast
News | Contrast Media | July 18, 2017
July 18, 2017 — Guerbet recently announced that it will phase out sales throughout the world of two products: Hexabri
ACR Offers Revised Contrast Media in Imaging Manual
News | Contrast Media | July 17, 2017
The American College of Radiology (ACR) recently revised its authoritative guide for the safe and effective use of...
FDA says gadolinium retention in the brain is not a safety issue
Feature | Magnetic Resonance Imaging (MRI) | May 25, 2017
A U.S. Food and Drug Administration (FDA) review of the safety ramifications of gadolinium-based contrast agents for...
Targeted MRI Could Pinpoint Aggressive Prostate Cancers Before They Spread

The ZD2-Gd probe, represented by the orange ball and green arrow, binds to the EDB-FN in the prostate cancer cells with high metastatic potential. This results in a strong MRI signal (upper right). Prostate cancer cells with low metastatic potential have no EDB-FN and so there is no MRI signal (lower right). Credit: Han, et al., Bioconjug Chem-Apr-2017

News | Prostate Cancer | May 24, 2017
A research team funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) has engineered a...
Scientists Develop Novel Chemical Dye to Improve MRI Liver Cancer Imaging
News | Magnetic Resonance Imaging (MRI) | May 03, 2017
May 3, 2017 — Scientists from the National University of Singapore (NUS) have developed a novel nanodiamond-based ...
Sponsored Content | Case Study | Contrast Media Injectors | April 13, 2017
The volume of computed tomography (CT) imaging exams continues to grow in the United States,[2] adding pressure to...
PRAC, European Medicines Agency, gadolinium-based contrast agents, safety recommendations, brain MRI
News | Contrast Media | March 13, 2017
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recently released new...
Overlay Init